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Abstract 
Background: Functional tricuspid valve regurgitation secondary to left-sided valve 
disease is common. DeVega repair is simple, but residual regurgitation with 
subsequent impairment of the right ventricular function is a concern. This study 
aims to compare tricuspid valve repair using DeVega vs. ring annuloplasty and their 
impact on the right ventricle in the early postoperative period and after six months. 
Methods: This is a prospective cohort study of 51 patients with rheumatic heart 
disease who underwent tricuspid valve repair for secondary severe tricuspid 
regurgitation. Patients were divided into two groups: group A; DeVega repair 
(n=34) and group B; ring annuloplasty repair (n=17). Patients were assessed 
clinically and by echocardiography before discharge and after six months for the 
degree of tricuspid regurgitation, right ventricular diameter and tricuspid annular 
plane systolic excursion (TAPSE). 
Results: Preoperative echocardiographic assessment showed no difference in left 
ventricular end-systolic diameter, end-diastolic diameter, ejection fraction and 
right ventricular diameter, however; group A had significantly better preoperative 
right ventricular function measured by TAPSE (1.96 ± 0.27 vs1.75 ± 0.31 cm; 
p=0.02). Group B had significantly longer cardiopulmonary bypass time (127.65 ± 
13.56 vs. 111.74 ± 18.74 minutes; p= 0.003) and ischemic time (99.06 ± 11.80 vs. 
87.15 ± 16.01 minutes; p= 0.009). Pre-discharge, there was no statistically 
significant difference in the degree of tricuspid regurgitation, but the right 
ventricular diameter was significantly lower in group B (2.66 ± 0.41 and 2.40 ± 0.48 
cm; p=0.049). After six months of follow up, the degree of tricuspid regurgitation 
(p= 0.029) and the right ventricular diameter were significantly lower in the ring 
annuloplasty group (2.56 ± 0.39 and 2.29 ± 0.44 cm; p=0.029). Although there was 
a statistically significant difference in preoperative TAPSE, this difference 
disappeared after six months. 
Conclusion: Both DeVega and ring annuloplasty techniques were effective in the 
early postoperative period, ring annuloplasty was associated with lesser residual 
regurgitation and better right ventricular remodeling in severe functional tricuspid 
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The tricuspid valve (TV) is commonly known as 
the forgotten valve because it is less frequently 
addressed in the literature [1]. Functional 
tricuspid valve regurgitation (TR) secondary to 
left-sided valve lesion is a common cause of TV 
disease [2]. A growing body of evidence suggests 
that ignoring a significant functional tricuspid 
regurgitation (TR) at the time of surgery for left-
sided lesions will negatively affect the long-term 
outcome of the patient [3, 4].  
The American College of Cardiology/American 
Heart Association (ACC/AHA), as well as the 
European Society of Cardiology (ESC) guidelines 
for management of valvular heart disease, agreed 
that intervention for functional tricuspid 
regurgitation is indicated in patients with severe 
TR, moderate TR with either tricuspid annular 
dilatation (greater than 40 mm) or tricuspid index 
higher than 21 cm/m2 [5, 6]. 
Non-prosthetic DeVega repair is a simple 
repair technique; however, there are concerns 
regarding residual TR, recurrence of symptoms, 
right ventricular functional impairment and 
subsequent poor patient functional status which 
lead to the introduction of prosthetically 
supported repairs [7, 8]. 
Current recommendations of TV repair 
technique remain controversial. This study aims to 
assess the early and midterm outcome of DeVega 
versus ring annuloplasty in severe functional 
tricuspid and their impact on right ventricular 
function and dimension in the early postoperative 
period and after six months. 
Patients and Methods: 
Patients cohort 
After institutional review boards (IRB) 
approval, we performed a prospective cohort 
study of 51 consecutive rheumatic patients with 
severe functional TR who presented in the period 
between 2016-2019 for mitral valve or mitral and 
aortic valve surgery. Informed consent was 
obtained from all patients enrolled in the study. 
We excluded ischemic heart disease patients, 
organic TV disease, and patients with associated 
congenital anomalies from our study. We divided 
patients into two groups (group A) who had 
DeVega repair (n=34) and (group B) who had ring 
annuloplasty repair (n=17). We compared the 
clinical and echocardiographic data before 
discharge and after six months of follow up. 
Preoperative data. 
In group A, 12 patients complained of 
dyspnea grade II; on the other hand, six patients 
in group B had grade II dyspnea. Twenty-one 
patients in group A had grade III dyspnea in 
contrast to 10 patients in group B. One patient in 
each group had grade IV dyspnea. There was no 
statistically significant difference between both 
groups in clinical data. There was no significant 
difference in both groups regarding left 
ventricular end-systolic diameter (LVESD), left 
ventricular end-diastolic diameter (LVEDD), 
ejection fraction (EF), pulmonary artery systolic 
pressure (PASP), and right ventricular diameter 
(RVD). The transannular plane systolic excursion 
(TAPSE) was significantly higher in DeVega group 
(P value= 0.017) (Table 1). 
Operative technique 
All patients had the operation performed 
through a median sternotomy, cardiopulmonary 
bypass, and antegrade crystalloid cardioplegia 
with systemic cooling. Mitral valve replacement 
was performed in all patients. Three patients in 
group A had concomitant aortic valve replacement 
in contrast to one patient in group B. After 
completion of left-sided valve surgery, both vena 
cavae were snared, and the right atrium was 
opened to repair the tricuspid valve on the 
arrested heart. In DeVega patients, a double-
armed 3-0 poly-propylene stitch with Teflon 
pledgets was used starting at the posteroseptal 
commissure reaching the anteroseptal 
commissure aiming to decrease the annulus size at 
the level of posterior and anterior leaflets. The 
degree of narrowing of the annulus was controlled 
over a valve sizer, (25- 29 mm).  
In the ring annuloplasty group, we used 
Contour 3D Annuloplasty rings (Medtronic, 
California, US). U shaped 2-0 braided polyester 
stitches were applied to the annulus from the 
anteroseptal commissure to the posteroseptal 
commissure. The size of the ring was determined 
by the length of the septal leaflet. Stitches were 
applied to the ring and tied. The intra-operative
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Table 1: The preoperative clinical characteristics and echocardiographic data. (continuous variables are presented as 
mean ± standard deviation and categorical variables as number and percent) 
Group A (n= 34) Group B (n= 17) P-value 
Male 11 (32.4%) 6 (35.3%) 0.834 
Age (years) 43.79 ± 14.87 45.53 ± 14.47 0.694 
Mitral valve disease 34 (100.0%) 17 (100.0%) -- 
Mitral stenosis 11 (32.4%) 6 (35.3%) 0.503 
Mitral regurgitation 7 (20.6%) 5 (29.4%) 0.834 
Double mitral lesion 16 (47.1%) 6 (35.3%) 0.424 
Aortic valve disease 3 (8.8%) 1 (5.9%) >0.99 
Severe Tricuspid regurgitation 34 (100.0%) 17 (100.0%) -- 
LVESD (cm) 3.91 ± 0.61 4.02 ± 0.47 0.520 
LVEDD (cm) 5.18 ± 0.66 5.38 ± 0.68 0.324 
EF% 57.82 ± 5.30 56.06 ± 5.76 0.281 
TAPSE (cm) 1.96 ± 0.27 1.75 ± 0.31 0.017 
PASP 58.26 ± 14.44 64.24 ± 20.95 0.239 
RV diameter (cm) 2.72 ± 0.46 2.46 ± 0.49 0.076 
LVESD; left ventricular end-systolic diameter, LVEDD; left ventricular end-diastolic diameter, EF; ejection 
fraction, TAPSE; trans annular plane systolic excursion, PASP; pulmonary artery systolic pressure, RV; 
right ventricle 
assessment was done by bulb syringe test, and in 
most cases repair was desirable.  
Definitions 
Dyspnea was assessed according to New York 
Heart Association (NYHA) functional classification 
[9]. We determined the severity of tricuspid 
regurgitation by 2D echocardiography and 
classified it as trace, mild (<5cm2), moderate (5-
10 cm2) severe (>10 cm2) according to the 
regurgitant jet area [10]. We determined the RV 
function according to TAPSE value. Normal value is 
more than 1.7cm. Right ventricular (RV) diameter 
was measured at the mid cavity [11]. 
Statistical analysis 
Data entry and analysis were performed using 
SPSS version 19 (Statistical Package for Social 
Science, IBM Corp- Chicago- IL- USA). Data were 
presented as numbers, percentage, mean, and 
standard deviation. Chi-square test and Fisher 
Exact test were used to compare qualitative 
variables. Independent samples t-test test was 
used to compare two quantitative variables in 
both groups. Paired samples t-test was done to 
compare preoperative and postoperative 
quantitative variables in the same group. P-value 
was considered statistically significant when < 
0.05.
Table 2: Operative and postoperative outcomes. (continuous variables are presented as mean± standard deviation and 
categorical variables as number and percent) 
Group A (n= 34) Group B (n= 17) P-value 
CPB time (min) 111.74 ± 18.74 127.65 ± 13.56 0.003 
Cross clamp time (min) 87.15 ± 16.01 99.06 ± 11.80 0.009 
Post-operative bleeding 3 (8.8%) 0 0.542 
Re-exploration for bleeding 3 (8.8%) 0 0.542 
Duration of MV (hours) 6.71 ± 3.54 5.94 ± 2.14 0.418 
ICU stay (days) 2.44 ± 0.70 2.59 ± 1.28 0.597 
Hospital stay (days) 9.79 ± 1.87 9.24 ± 3.56 0.464 
CPB; cardiopulmonary bypass, MV; mechanical ventilation, ICU; intensive care unit 
136
Results 
Cardiopulmonary bypass and ischemic times 
were higher in group B (p-value= 0.003 and 0.009; 
respectively). There were no mortalities in both 
groups. All patients had a smooth postoperative 
course, as summarized in Table 2. 
Pre-discharge clinical data 
In group A, two patients complained of 
dyspnea grade II, and no patient had lower limb 
edema. In group B, one patient complained of 
dyspnea grade II, and no patient had lower limb 
edema. 
Pre-discharge echocardiographic data 
Echo data before discharge showed that all 
patients had well-functioning prosthetic mitral 
and aortic valves. Both TAPSE (P=0.050) and RV 
diameter (P =0.049) were higher in group A, as 
shown in Table 3. 
Clinical data after six month 
In group A, two patients had dyspnea grade II, 
and two patients had lower limb edema. Two 
patients had hospital readmission for right-sided 
heart failure. In group B, no patient had dyspnea, 
lower limb edema, or hospital readmission for 
right-sided heart failure. There was no significant 
difference in clinical data between both groups 
(p=0.5). 
Echocardiographic data after six months 
All patients in group A and B had well-
functioning prosthetic valves after six months. RV 
diameter was significantly higher in group A (P-
value = 0.029). There was a significant difference 
in residual tricuspid regurgitation between both 
groups, which was better in group B (P=0.029), as 
shown in Table 4. 
Right ventricular function as measured by 
TAPSE improved significantly in the early 
postoperative period and after six months in both 
groups (p< 0.005). Although there was a 
statistically significant difference in preoperative 
and early postoperative TAPSE, this difference 
disappeared after six months (Figure 1). PASP 
improved in the early postoperative period and 
after six months in both groups (p< 0.005) (Figure 
2). 
Discussion 
Management of moderate or lesser degree of 
functional tricuspid valve regurgitation secondary 
to left-sided valve disease is still controversial. 
However, the long-term outcome is improved 
after correction of severe tricuspid regurgitation 
during left-sided valve surgery.  The ideal repair 
technique is still a subject of ongoing researches. 
Table 3: Echocardiographic data before discharge. (continuous variables are presented as mean± standard deviation 
and categorical variables as number and percent) 
Group A (n= 34) Group B (n= 17) P-value 
Degree of tricuspid regurgitation 
Trace 5 (14.7%) 4 (23.5%) 
0.719 Mild 19 (55.9%) 9 (52.9%) 
Moderate 10 (29.4%) 4 (23.5%) 
LVESD (cm) 3.83 ± 0.56 3.94 ± 0.48 0.486 
LVEDD (cm) 5.02 ± 0.56 5.11 ± 0.74 0.616 
EF (%) 56.62 ± 3.30 55.12 ± 3.94 0.158 
TAPSE (cm) 2.05 ± 0.27 1.86 ± 0.40 0.05 
EPASP (mmHg) 34.82 ± 5.70 36.24 ± 7.40 0.454 
RV diameter (cm) 2.66 ± 0.41 2.40 ± 0.48 0.049 
LVESD; left ventricular end-systolic diameter, LVEDD; left ventricular end-diastolic diameter, EF; ejection 
fraction, TAPSE; trans annular plane systolic excursion, EPASP; estimated pulmonary artery systolic 
pressure, RV; right ventricle 
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Table 4: Echocardiographic data after six months. (continuous variables are presented as mean± standard deviation 
and categorical variables as number and percent) 
Group A (n= 34) Group B (n= 17) P-value 
Degree of tricuspid regurgitation 
Trace 4 (11.8%) 7 (41.2%) 
0.029 
Mild 17 (50%) 9 (52.9%) 
Moderate 9 (26.5%) 1 (5.9%) 
Severe 4 (11.8%) 0 
ESD (cm) 3.70 ± 0.49 3.88 ± 0.45 0.198 
EDD (cm) 4.92 ± 0.54 5.11 ± 0.49 0.245 
EF (%) 58.15 ± 2.95 57.47 ± 3.57 0.475 
TAPSE (cm) 2.11 ± 0.25 1.99 ± 0.28 0.137 
PASP (mmHg) 31.38 ± 6.72 31.59 ± 5.94 0.915 
RV diameter (cm) 2.56 ± 0.39 2.29 ± 0.44 0.029 
LVESD; left ventricular end-systolic diameter, LVEDD; left ventricular end-diastolic diameter, EF; ejection 
fraction, TAPSE; trans annular plane systolic excursion, PASP; pulmonary artery systolic pressure, RV; 
right ventricle 
Some investigators reported a high incidence 
of recurrence after DeVega repair, particularly in 
patients with severe annular dilatation, and they 
recommended the use of annuloplasty rings to 
obtain a more durable repair [7,8]. Few studies 
reported the effect of each repair on right 
ventricular function and remodeling, which may 
have an impact on long-term survival. In our 
research, we examined the effect of each repair 
technique on TAPSE and RV diameter. 
Figure 1: Tricuspid annular plane systolic excursion 
(TAPSE) at the baseline, early postoperative period, 
and after six months of follow up 
This study shows no statistically significant 
difference between DeVega repair and ring 
annuloplasty in term of degrees of tricuspid 
regurgitation in the early postoperative period (p= 
0.719), but there was significant difference after 
six months between both groups which was better 
with ring annuloplasty (p value= 0.029). 
Additionally, there was significant difference in 
bypass and ischemic time which was higher in ring 
group (p values= 0.003 and 0.009; respectively), 
but the longer ischemic time is accepted for the 
more durable repair of the tricuspid valve. 
Our result is consistent with Basel and 
colleagues [12] who studied 129 patients with 
severe secondary tricuspid regurgitation and 
found that the number of patients who developed 
residual TR was significantly lower in the ring 
group. Ren and colleagues [13] found that ring 
annuloplasty was associated with improved 
survival, decreased TR recurrence and higher 
quality of life in rheumatic heart disease patients 
undergoing tricuspid valve repair combined with 
mitral and/or aortic valve replacement. 
Matsuyama and colleagues [14] retrospectively 
studied 45 patients who underwent surgery for 
secondary TR, and they found that there was a 
significant difference in TR recurrence between 
the groups (p = 0.027), but no significant 
difference in NYHA class. These results are 
consistent with our results. On the other hand, 
Khallaf and colleagues [15], Abdelfattah and 
colleagues [16], and Dokhan and colleagues [17] 
found that there was no statistically significant 
difference between DeVega and ring repair in the 
early postoperative period and during follow up. 
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Figure 2: Pulmonary artery systolic pressure (PASP) at 
baseline, early postoperative, and after six months 
We found that the right ventricular function 
measured by TAPSE improved significantly in the 
early postoperative period and after six months in 
both groups. The Immediate improvement in 
TAPSE in the early postoperative period may be 
attributed to the reduction in PASP and RV 
afterload in both groups postoperatively. 
Although there were statistically significant 
differences in preoperative and early 
postoperative TAPSE between both groups, this 
difference disappeared after six months. Desai 
and colleague [18] studied right ventricular 
function after mitral valve surgery with or without 
concomitant tricuspid valve repair, and they found 
that in patients with mitral valve disease and 
severe TR, mitral valve repair alone was associated 
with improved TR and right ventricular function 
early after surgery, as mitral valve surgery with 
concomitant tricuspid valve repair do.  
After TV repair, this improvement continued, 
but without TV repair, RV function started to 
progressively decline at six months in parallel with 
the return of TR to the preoperative level. At three 
years, TAPSE was normal after TV repair. However, 
without TV repair, both TR and RV dysfunction had 
returned to preoperative levels. This study reflects 
the importance of competent repair on TAPSE and 
RV function on long-term outcome. 
In our study, we found a statistically significant 
difference in RV diameter between both groups 
early and after six months (p value= 0.049 and 
0.029; respectively), despite improvement in both 
groups. These results support that concomitant 
tricuspid valve repair secondary to the left-sided 
lesion is vital for right ventricular remodeling and 
remodeling is better with ring repair. Philippe and 
colleagues [19] found similar results when they 
observed the change in RV geometry in TV repair 
patients. Only in control patients, indexed RV end-
diastolic area increased significantly. In TV repair 
patients, there was a significant decrease in RV 
end-diastolic area, and they concluded that adding 
TV repair to mitral valve surgery in patients with 
more than moderate TR leads to favorable 
changes in RV geometry and prevents 
postoperative RV dilation. 
Study limitations 
This study has the following limitations: first, it is a 
single-center study of small numbers of patients. 
Secondly, the method of tricuspid repair was 
chosen by the operating surgeon; therefore, there 
is a possibility of selection bias. Lastly, the study is 
not a randomized clinical trial, and several factors 
could have affected the outcome other than the 
repair method. However, the study evaluated the 
two repair techniques in a special subset of 
patients with rheumatic heart disease who are 
understudied in the literature. 
Conclusion 
Both DeVega and ring annuloplasty techniques 
for management severe functional secondary 
tricuspid regurgitation are effective in the early 
postoperative period. However, ring annuloplasty 
was associated with lesser residual regurgitation, 
and better right ventricular remodeling in 6-
months follow up. 
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